landiolol has been researched along with Acute Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, S; Hideaki, S; Hizawa, N; Inoue, Y; Jesmin, S; Kawano, S; Khatun, T; Kiwamoto, T; Matsuishi, Y; Mizutani, T; Mowa, CN; Shimojo, N; Tsunoda, Y; Zaedi, S | 1 |
1 other study(ies) available for landiolol and Acute Lung Injury
| Article | Year |
|---|---|
Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.
Topics: Acute Lung Injury; Adrenergic beta-Antagonists; Animals; Down-Regulation; Endothelin-1; Lung; Male; Morpholines; Rats, Wistar; RNA, Messenger; Sepsis; Tumor Necrosis Factor-alpha; Urea | 2016 |